Evista and the generic alternative Raloxifene affect the cycle of bone formation and breakdown in the body, and reduce loss of bone tissue. Evista is used to treat or prevent osteoporosis in postmenopausal women. This medication is also used to reduce the risk of invasive breast cancer in postmenopausal women who have osteoporosis or who are otherwise at risk of invasive breast cancer.
Evista is not a cancer medication and will not treat breast cancer.
Raloxifene prevents and treats osteoporosis by mimicking the effects of estrogen (a female hormone produced by the body) to increase the density of your bones. In other parts of the body such as the uterus and breasts, Evista acts like an estrogen blocker. Raloxifene decreases the risk of developing invasive breast cancer by blocking the effects of estrogen on breast tissue. This may stop the development of tumors that need estrogen to grow.
Always read the patient information and instructions carefully before using this medication.
Make sure to tell your doctor and pharmacist:
Also be aware that:
Common side-effects may include but are not limited to:
Contact your doctor if you experience any of the following side-effects:
Q: What is the generic alternative to Evista?
A: The generic alternative to Evista is known as raloxifene. You can save up to 90% through by buying with us and raloxifene may offer even better savings on your medication.
Q: What is the strength of Evista?
A: Both Evista and raloxifene come in the strength of 60mg.
Q: Why is Evista prescribed?
A: Evista is used to treat or prevent osteoporosis in postmenopausal women. Evista is also used to reduce the risk of invasive breast cancer in postmenopausal women who have osteoporosis or who are otherwise at risk of invasive breast cancer.